Pfizer to exit GSK's consumer health arm after spin-off
Pfizer previously signalled it would seek to sell its shareholding in Haleon, the world's largest consumer health business and home to Sensodyne toothpaste and Advil painkillers.01-06-2022
01-06-2022
US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
On Tuesday, the CDC, citing case reports and concerns that relapsed patients could spread the virus, issued its advisory that Paxlovid users should isolate for a second five days if symptoms rebound28-05-2022
PFIZER LTD. - 500680 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of Regulation 24(A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, Secretarial Compliance Report for the year ended March 31, 2022, issued by Mr. K. G. Saraf, Practicing Company Secretary. We request you to kindly take the above on record.26-05-2022
WEF 2022: Pfizer commits medicines, vaccines to 45 lower-income countries
The initiative by Pfizer was launched at the World Economic Forum Annual Meeting in Davos 202226-05-2022
Buy Pfizer; target of Rs 4810: ICICI Direct
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4810 in its research report dated May 23, 2022.24-05-2022
Pfizer's three-dose coronavirus vaccine 80% effective in young kids
Pfizer said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old24-05-2022
PFIZER LTD. - 500680 - Profile Of Statutory Auditors
We refer to our letter dated May 20, 2022, wherein the Company had informed that, the Board of Directors of the Company at their Meeting held on May 20, 2022, had recommended appointment of M/s. B S R & Co. LLP, Chartered Accountant (Firm Registration No. 101248W/W100022) as the Statutory Auditors of the Company for a period of 5 (five) consecutive years from the conclusion of the ensuing 71st Annual General Meeting of the Company till the conclusion of the 76th Annual General Meeting subject to the approval of the shareholders of the Company. We enclosed herewith a brief profile of M/s. B S R & Co. LLP, Chartered Accountant.23-05-2022
Mid-cap pharma stock Pfizer recommends 350% dividend. Details here
Dividend paying stock: Pfizer share price today is around 4400. So, if we compare 35 dividend for FY2021-22 with Pfizer share price today, then mid-cap pharma majors annual dividend yield would fall around 0.80 per cent23-05-2022
PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
This is to inform you that the Statutory Auditors of the Company, M/s. Walker Chandiok & Co LLP would be completing their term of 5 years at the ensuing Annual General Meeting ofthe Company. Consequently, based on the recommendation of the Audit Committee of the Company, the Board of Directors ofthe Company at its meeting held today, i.e., May 20, 2022, recommended appointment of M/s. B S R & Co. LLP, Chartered Accountant (Firm Registration No. 101248W/W-100022) as the Statutory Auditors of the Company. Accordingly, M/s. BS R & Co. LLP will hold office for a period of 5 (five) consecutive years from the conclusion of the ensuing 71st Annual General Meeting of the Company till the conclusion of the 76th Annual General Meeting subject to the approval of the shareholders of the Company.20-05-2022
PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors have at its Meeting held today, i.e., May 20, 2022, recommended a dividend of Rs. 35/- per equity share of Rs. 10/- each {350%) for the financial year ended March 31, 2022. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 23, 2022.20-05-2022